XGN
Exagen Inc
NASDAQ: XGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.90
+5.07% today
Updated 2026-04-30
Market cap
$65.91M
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$3 – $12
Volume
0.3M
Exagen Inc (XGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |